Claims
- 1. A method for preventing vascular leak syndrome comprising administering to a mammalian species in need thereof a therapeutically effective amount of a non-steroidal antiinflammatory agent selected from the group consisting of indomethacin, piroxicam, meclofenanate, naproxen, ibuprofen and aspirin.
- 2. The method according to claim 1, wherein the non-steroidal anti-inflammatory agent is indomethacin.
- 3. The method according to claim 1 wherein the non-steroidal anti-inflammatory agent is piroxicam.
- 4. The method according claim 1 wherein the vascular leak syndrome is caused by a biological molecule.
- 5. The method according to claim 4 wherein the biological molecule is a cytokine.
- 6. The method according to claim 4 wherein the biological molecule is an interferon.
- 7. The method according to claim 4 wherein the biological molecule is an immunotoxin.
- 8. The method according to claim 7 wherein the immunotoxin is BR96 sFv-PE40.
- 9. The method according to claim 1 wherein the mammalian species is a human.
Parent Case Info
This application is a divisional of application Ser. No. 08/293,351, filed Aug. 19, 1994, which application is incorporated herein in its entirety by reference.
US Referenced Citations (1)
Number |
Name |
Date |
Kind |
5278143 |
Shepro et al. |
Jan 1994 |
|
Divisions (1)
|
Number |
Date |
Country |
Parent |
293351 |
Aug 1994 |
|